ATAI Life Sciences Investor

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.


Invests into

Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: Munich, Bayern, Germany
Founded Date: 2018-01-01
Investor Type: Corporate Venture Capital
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Last Funding Date: 2022-08-15
Total Funding: 522100000.0
Technology: Mental Health Telecare
Employee Number: 11-50
Number Of Exists: 2
Acquisitions Number: Made Acquisitions
Estimated Revenue: $1M to $10M
Investors Number: 38.0
Industry: Blockchian and Crypto